Psychedelic News2022-09-26T12:49:02+02:00

News and Press Releases


GOODMIND Available For Sale In The United Kingdom And Europe – Exclusive Distribution Agreement Concluded With This Works.

November 29, 2022|

Psyence is pleased to announce that it has, together with its joint venture partner The Goodleaf Company (Pty) Ltd (“Goodleaf”), entered into an exclusive distribution agreement with This Works Products Limited (“This Works”) for the distribution and sale of the joint venture’s functional mushroom brand, GOODMINDTM, in the United Kingdom and Europe.

Psyence Group Announces Strategic Private Placement

November 10, 2022|

Psyence announce that it has received subscription agreements for gross proceeds of CAD$1.22 million from a consortium led by Brandon Kerzner, a member of the globally recognised Kerzner family. Brandon has a focus on investing in technology and life science advancement industries.

News and Press Releases

Psyence In The News

Psyence wins ISO certification from
British Standards Institute for
psilocybin production facility
Psyence Group’s functional mushroom brand
to be sold in South Africa’s
largest coffee retail chain
Psyence Group begins trading on the
OTCQB platform in New York
to satisfy investor demand
Psyence Group launches its functional
mushroom products under the
GOODMIND banner in South Africa
In this interview with Proactive Investors, Dr. Neil Maresky
talks about his appointment as
CEO of Psyence Group.
Psyence Group ‘delighted’ to reach
psilocybin product development
agreement with Jamaican government

Market For Psychedelic Drugs Expected to Reach $6.9 Billion By 2027

Psychedelic Finance chats to Psyence CEO Jody Aufrichtig

Psyence looking to be a major player
in psychedelics using their federally
licensed facilities
Jody Aufrichtig in conversation
with the CSE’s
Barrington Miller
Go to Top